No Reason to Feel Sick? Nocebo Responses in the Placebo Arms of Experimental Endotoxemia Studies

Frontiers in Psychiatry
Sven Benson, Sigrid Elsenbruch

Abstract

Adverse side effects are reported by a large proportion of patients undergoing medical treatment in clinical practice or clinical trials. Nocebo effects, induced by negative treatment expectancies, can contribute to negative patient-reported outcomes but have rarely been studied in the context of inflammatory or immune-related conditions. Based on perceived treatment allocation, we herein analyzed nocebo responders in the placebo arms of randomized controlled double-blind experimental endotoxemia studies. We hypothesized that nocebo responders would report more bodily sickness symptoms and greater mood impairment. Out of N = 106 participants who had all received placebo injection, N = 20 (18.9%) wrongly believed they had received endotoxin and were thus considered as nocebo responders. Nocebo responders reported significantly more bodily sickness symptoms, suggesting that the perception of bodily symptoms affected perceived treatment allocation. Against our expectations, we did not find differences between nocebo responders and controls in psychological or physiological parameters. However, exploratory correlational analysis within nocebo responders revealed that more pronounced bodily sickness symptoms in response to placebo w...Continue Reading

References

Sep 1, 1987·Clinical Pharmacology and Therapeutics·M G MyersJ Singer
Feb 7, 2002·JAMA : the Journal of the American Medical Association·Arthur J BarskyJonathan F Borus
Jul 28, 2007·The Journal of Sexual Medicine·Nicola MondainiRiccardo Bartoletti
Sep 18, 2007·Current Opinion in Anaesthesiology·Luana Colloca, Fabrizio Benedetti
Oct 7, 2011·Clinical Pharmacology and Therapeutics·W RiefP Enck
Mar 16, 2012·The American Journal of Bioethics : AJOB·Rebecca Erwin Wells, Ted J Kaptchuk
Jul 4, 2012·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·V KotsisS Elsenbruch
Mar 2, 2013·Nature Reviews. Drug Discovery·Paul EnckWinfried Rief
Feb 5, 2014·Brain, Behavior, and Immunity·Manfred SchedlowskiJan-Sebastian Grigoleit
Jul 9, 2014·JAMA : the Journal of the American Medical Association·Ulrike Bingel, UNKNOWN Placebo Competence Team
Apr 18, 2015·Brain, Behavior, and Immunity·Sven BensonSigrid Elsenbruch
Sep 12, 2015·The American Journal of Psychiatry·Janice K Kiecolt-GlaserChristopher P Fagundes
Oct 17, 2017·Rheumatology and Therapy·Mourad F Rezk, Burkhard Pieper
Oct 17, 2017·Pain Reports·Regine KlingerLuana Colloca
Dec 12, 2017·Translational Psychiatry·Sven BensonSigrid Elsenbruch
Apr 24, 2018·International Review of Neurobiology·Julian Kleine-Borgmann, Ulrike Bingel
Apr 24, 2018·International Review of Neurobiology·Martin HadamitzkyManfred Schedlowski
Aug 25, 2018·Expert Review of Clinical Immunology·Rosanne M SmitsAndrea W M Evers
Nov 8, 2018·Behavioural and Cognitive Psychotherapy·Andrew DenovanGeorge Lofthouse

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.